The oncogenic role of NS5A of hepatitis C virus is mediated by up-regulation of survivin gene expression in the hepatocellular cell through p53 and NF-κB pathways

Cell Biology International

Volumn 35, Issue 12, 2011, Pages 1225-1232

  Jiang, Yong Fang ^a   He, Bo ^a   Li, Nai Ping ^a   Ma, Jing ^a   Gong, Guo Zhong ^a   Zhang, Min ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Hepatitis C virus (HCV); Non structural protein (NS); Nuclear factor B (NF B); p53; Survivin

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CYCLIN D1; DNA; HOE 33342; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE SYNTHASE; NONSTRUCTURAL PROTEIN 5A; PROTEIN P53; SURVIVIN;

APOPTOSIS; ARTICLE; CELL COUNT; CELL DIVISION; CELL PROLIFERATION; CELL STRAIN HEPG2; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PROTEIN DEGRADATION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; VALIDATION PROCESS; WESTERN BLOTTING;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; DOWN-REGULATION; GENE EXPRESSION; HEP G2 CELLS; HEPACIVIRUS; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF APOPTOSIS PROTEINS; LIVER NEOPLASMS; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; ONCOGENES; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 80955139377     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20110102     Document Type: Article

References (34)

1. Ai A, Yin L, Zhou X, Zhu D, Yu Y, Feng Y. Inhibition of surviving reduces cell proliferation and induces apoptosis in human endometrial cancer. Cancer 2006;107:746-56.
2. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997;3:917-21.
3. Ambrosini G, Adida C, Sirugo G, Altieri DC. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem 1998;273:11177-82.
4. Anzola M. Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis. J Viral Hepat 2004;11:383-93.
5. Cappello F, Bellafiore M, Palma A, Bucchieri F. Defective apoptosis and tumorigenesis: role of p53 mutation and Fas/FasL system dysregulation. Eur J Histochem 2002;46:199-208.
6. Colombo M. Hepatitis C virus and hepatocellular carcinoma. Baillieres Best Pract Res Clin Gastroenterol 1999;13:519-28.
7. De Mitri MS, Cassini R, Bagaglio S, Morsica G, Andreone P, Marino N et al. Evolution of hepatitis C virus non-structural 5A gene in the progression of liver disease to hepatocellular carcinoma. Liver Int 2007;27:1126-33.
8. El-Attar HA, Kandil MH, El-Kerm YM, El-Ghandour MK. Comparison of serum survivin and alpha fetoprotein in Egyptian patients with hepatocellular carcinoma associated with hepatitis C viral infection. Asian Pac J Cancer Prev 2010;11:897-903.
9. Girard S, Vossman E, Misek DE, Podevin P, Hanash S, Bréchot C et al. Hepatitis C virus NS5A-regulated gene expression and signaling revealed via microarray and comparative promoter analyses. Hepatology 2004;40:708-18.
10. Gong G, Waris G, Tanveer R, Siddiqui A. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-κB. Proc Natl Acad Sci USA 2001;98:9599-604.
11. Kotsinas A, Pateras IS, Galanos PS, Karamouzis MV, Sfikakis PP, Gorgoulis VG. Why is p53-inducible gene 3 rarely affected in cancer? Oncogene 2010;29:5220.
12. Kröncke KD. Nitrosative stress and transcription. Biol Chem 2003;384:1365-77.
13. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 1998;17:3247-59.
14. Lan KH, Sheu ML, Hwang SJ, Yen SH, Chen SY, Wu JC et al. HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis. Oncogene 2002;21:4801-11.
15. Lens SM, Medema RH. The survivin/Aurora B complex: its role in coordinating tension and attachment. Cell Cycle 2003;2:507-10.
16. Levrero M. Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene 2006;25:3834-47.
17. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC et al. Control of apoptosis and mitotic spindle checkpoint by surviving. Nature 1998;369:580-4.
18. Mi J, Zhang X, Rabbani ZN, Liu Y, Su Z, Vujaskovic Z et al. H1 RNA polymerase III promoter-driven expression of an RNA aptamer leads to high-level inhibition of intracellular protein activity. Nucleic Acids Res 2006;34:3577-84.
19. Mirza A, McGuirk M, Hockenberry TN, Wu Q, Ashar H, Black S et al. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene 2002;21:2613-22.
20. Muchmore SW, Chen J, Jakob C, Zakula D, Matayoshi ED, Wu W et al. Crystal structure and mutagenic analysis of the inhibitor-ofapoptosis protein surviving. Mol Cell 2006;6:173-82.
21. Olie RA, Simões-Wüst AP, Baumann B, Leech SH, Fabbro D, Stahel RA et al. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res 2000;60:2805-9.
22. Otaki M, Hatano M, Kobayashi K, Ogasawara T, Kuriyama T, Tokuhisa T. Cell cycle-dependent regulation of TlAP/m-survivin expression. Biochim Biophys Acta 2000;149:188-94.
23. Pang R, Tse E, Poon RT. Molecular pathways in hepatocellular carcinoma. Cancer Lett 2006;240:157-69.
24. Park CY, Choi SH, Kang SM, Kang JI, Ahn BY, Kim H et al. Nonstructural 5A protein activates beta-catenin signaling cascades: implication of hepatitis C virus-induced liver pathogenesis. J Hepatol 2009;51:853-64.
25. Pluquet Q, Qu LK, Baltzis D, Koromilas AE. Endoplasmic reticulum stress accelerates p53 degradation by the cooperative actions of Hdm2 and glycogen synthase kinase 3beta. Mol Cell Biol 2005;25:9392-405.
26. Prasad AS. Zinc in human health: effect of zinc on immune cells. Mol Med 2008;14:353-7.
27. Sah NK, Khan Z, Khan GJ, Bisen PS. 'Structural, functional and therapeutic biology of survivin. Cancer Lett 2006;244:164-71.
28. Sarcar B, Ghosh AK, Steele R, Ray R, Ray RB. Hepatitis C virus NS5A mediated STAT3 activation requires co-operation of Jak1 kinase. Virology 2004;322:51-60.
29. Sauter D, Himmelsbach K, Kriegs M, Carvajal Yepes M, Hildt E. Localization determines function: N-terminally truncated NS5A fragments accumulate in the nucleus and impair HCV replication. J Hepatol 2009;50:861-71.
30. Schmitz U, Tan SL. NS5A-from obscurity to new target for HCV therapy. Recent Pat Antiinfect Drug Discov 2008;3:77-92.
31. Shi L, Zhang SL, Li K, Hong Y, Wang Q, Li Y et al. NS5ATP9, a gene up-regulated by HCV NS5A protein. Cancer Lett 2008;259:192-7.
32. Waris G, Tardif KD, Siddiqui A. Endoplasmic reticulum (ER) stress: hepatitis C virus induces an ER-nucleus signal transduction pathway and activates NF-κB and STAT-3. Biochem Pharmacol 2002;64:1425-30.
33. Yagihashi A, Asanuma K, Kobayashi D, Tsuji N, Torigoe T, Sato N et al. Autoantibodies to survivin in patients with chronic hepatitis and hepatocellular carcinoma.Autoimmunity 2005;38:445-8.
34. Zhang X, Li Y, Huang Q, Wang H, Yan B, Dewhirst MW et al. Increased resistance of tumor cells to hyperthermia mediated by integrinlinked kinase. Clin Cancer Res 2003;9:1155-60.